Skip to main content
Hans Hammers, MD, Oncology, Dallas, TX, University of Texas Southwestern Medical Center

HansJoergHammersMD

Oncology Dallas, TX

Genitourinary Oncology, Hematologic Oncology

Co-Leader Kidney Cancer Program

Dr. Hammers is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hammers' full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2005 - 2009
  • Johns Hopkins University/Bayview Medical Center
    Johns Hopkins University/Bayview Medical CenterResidency, Internal Medicine, 2002 - 2005

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 2016 - 2024
  • MD State Medical License
    MD State Medical License 2009 - 2022

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013-2014

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Vaccine Shows Promise in Renal Cell Carcinoma
    Vaccine Shows Promise in Renal Cell CarcinomaMarch 3rd, 2017
  • Expert Predicts PD-1/PD-L1 Agents as Backbone of Combination Therapy in RCC
    Expert Predicts PD-1/PD-L1 Agents as Backbone of Combination Therapy in RCCJanuary 6th, 2016
  • ASCO GU 2020: Combined Dual Checkpoint Inhibition and Stereotactic Body Radiotherapy in the Metastatic Renal Cell Carcinoma Setting (RADVAX RCC)
    ASCO GU 2020: Combined Dual Checkpoint Inhibition and Stereotactic Body Radiotherapy in the Metastatic Renal Cell Carcinoma Setting (RADVAX RCC)February 17th, 2020
  • Join now to see all

Professional Memberships

Other Languages

  • German

Hospital Affiliations